Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Medicus Pharma Ltd. issued 680,893 of common stock to YA II PN, Ltd. (Yorkville) for $1,500,905 aggregate.
- Security
- common stock
- Shares
- 680,893
- Purchaser
- YA II PN, Ltd. (Yorkville)
- Consideration
- $1,500,905 aggregate
Exact text from the filing
the Company completed sales of its common shares (the "Common Shares") to Yorkville (collectively, the "SEPA Advances") as disclosed in the table below: Date of Sale Number of Common Shares Price per share Approximate Aggregate Consideration October 28, 2025 250,000 $2.3760 $594,000 November 5, 2025 83,333 $2.2691 $189,091 November 5, 2025 14,659 $2.1825 $31,993 November 14, 2025 83,375 $2.2374 $186,543 November 14, 2025 4,526 $2.231 $10,098 November 20, 2025 33,333 $2.3423 $78,076 November 20, 2025 31,667 $2.2795 $72,185 November 28, 2025 66,667 $1.9462 $129,747 November 28, 2025 33,333 $1.9400 $64,666 December 4, 2025 33,333 $1.9587 $65,289 December 4, 2025 46,667 $1.6975 $79,217 Total 680,893 - $1,500,905
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Medicus Pharma Ltd. issued up to 4,020,000 Common Shares of warrant to accredited and institutional holder for amended exercise price of $1.92 per Common Share.
- Security
- warrant
- Shares
- up to 4,020,000 Common Shares
- Purchaser
- accredited and institutional holder
- Consideration
- amended exercise price of $1.92 per Common Share
Exact text from the filing
(the "Holder") to exercise existing warrants to purchase up to 2,680,000 of the Company's common shares ("Common Shares") issued on July 14, 2025 at an amended exercise price of $1.92 per Common Share (the "Existing Warrants"). Pursuant to the Agreement, the Holder, upon exercise, will receive new unregistered warrants (the "New Warrants") to purchase up to
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Medicus Pharma Ltd. entered into Warrant Inducement Agreement with a certain accredited and institutional holder valued at approximately $5.1 million (effective 2025-12-05).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- a certain accredited and institutional holder
- Value
- approximately $5.1 million
- Effective
- 2025-12-05
Exact text from the filing
On December 5, 2025, Medicus Pharma Ltd. (the "Company") entered into an inducement offer (the "Agreement") with a certain accredited and institutional holder (the "Holder") to exercise existing warrants to purchase up to 2,680,000 of the Company's common shares ("Common Shares") issued on July 14, 2025 at an amended exercise price of $1.92 per Common Share (the "Existing Warrants").
View on SEC.gov